AYUR.CN stock down 66.67% after CCAA filing: what investors should watch next

AYUR.CN stock fell sharply on market hours after Ayurcann Holdings Corp. filed for creditor protection under the CCAA. The share price closed at C$0.005, down -66.67%, on volume of 2,544,383 shares as investors reacted to the restructuring news. We explain how the CCAA filing, trading halts and company metrics drove the move, and show what metrics and milestones traders should monitor next for the CNQ-listed Canadian health-care firm.

AYUR.CN stock: immediate price action and news drivers

The headline driver was the CCAA filing announced Jan 30, 2026, which triggered CIRO trading halts and heavy selling. The stock opened at C$0.015 and recorded a day low of C$0.005 and high of C$0.015. Average daily volume is 84,668, so today’s volume of 2,544,383 represents a relative volume spike of 30.05x.

Regulatory filings say Ayurcann will run a sale process while operating under court protection. Trading status updates were posted by the monitor and by CIRO. See the company release and the CIRO halt notice for primary documents source and source.

AYUR.CN stock: valuation and balance-sheet metrics

At C$0.005, Ayurcann’s market cap is about C$973,519.00 with 194,703,863 shares outstanding. Trailing EPS is -0.03 and reported PE is -0.17, reflecting losses. Key ratios show low price-to-sales of 0.03 and negative book value per share at -0.02.

Liquidity and leverage are mixed. Current ratio is 0.61, cash per share is 0.0056, and debt-to-market-cap is 0.69. These figures help explain creditor protection as management seeks to restructure obligations.

AYUR.CN stock: technicals, volume and trading risk

Technically, short-term momentum signals were weak before the filing. RSI sits near 48.66 and ADX reads 38.79, indicating a strong trend driven by today’s sell-off. The 50-day average price was C$0.024 and the 200-day average was C$0.029, both well above today’s price.

High volatility and low quoted price increase execution risk. Market participants should expect wide spreads and possible trading halts on CNQ. We link the Meyka stock page for intraday tools and live depth: Meyka AYUR.CN page.

AYUR.CN stock: Meyka AI grade and analyst context

Meyka AI rates AYUR.CN with a score out of 100: 69.81 (Grade B — SUGGESTION: HOLD). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The grade balances recent operational revenue trends against solvency and liquidity concerns.

Independent company ratings show an external score of C with a sell recommendation dated Jan 29, 2026, highlighting valuation and cash concerns. Investors should treat ratings as one input, not a guarantee.

AYUR.CN stock: restructuring, risks and catalysts

The CCAA process creates a binary near-term path: a sale, recapitalization, or wind-down. Management expects operations to continue in the ordinary course while the sale process runs. Key catalysts include court approval of debtor-in-possession financing, qualified bidders for assets, and any CSE listing decisions.

Primary risks are loss of listing status, creditor recoveries that dilute equity, and ongoing regulatory costs. Upside scenarios need a credible bidder or successful restructuring that improves cash flow and restores listing eligibility on CNQ in Canada.

Final Thoughts

AYUR.CN stock is a top loser today after Ayurcann’s CCAA filing and related trading halts. The market punished shares quickly: price fell to C$0.005, off -66.67%, on heavy volume 2,544,383. Fundamentals show small market capitalization C$973,519.00, negative EPS -0.03, low current ratio 0.61, and negative book value per share -0.02, underscoring solvency pressure. Meyka AI’s forecast model projects monthly C$0.0300, yearly C$0.01728, and three-year C$0.00699 figures. Versus the current price (C$0.005), those forecasts imply +500.00%, +245.70%, and +39.87% moves respectively. Forecasts are model-based projections and not guarantees. In short, this stock now trades as a distressed equity: watch court filings, monitor the Monitor’s website and CIRO notices, and expect high volatility while the sale process unfolds. We use Meyka AI as an AI-powered market analysis platform to flag catalysts and model outcomes, but these grades and projections are not financial advice.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.